Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.
Also called NCT01164592
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 312 participants
- Sponsor
- Registry
-
NCT01164592
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Czechia, Finland, France, Germany, Netherlands, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01164592. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2015-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
- Acronym
- MS
- Condition
- Heart Failure
- Condition
- Sleep Disorder
- Condition
- Cheyne Stokes Respiration
- Intervention (Device)
- adaptive servoventilation (ASV)
- Lead sponsor
- ResMed
Record details
- Record id
cardio:ct-nct01164592- Content hash
6744d98aa8fe45df8838615c31e6df98abec1b01a52e75357810c07866098423